Hot penny stocks... don't get burned
   

News for Immunomedics, Inc (IMMU)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Immunomedics Inc.  (IMMU) 
|
$ 1.36      -0.22 (-13.92%) Volume: 558.56 k 4:00 PM EDT Oct 7, 2008
Wed, Sep 17, 2008
11:31 AM Immunomedics Highlights Progress With Clinical Programs At R&D Day - GlobeNewswire
Mon, Sep 08, 2008
8:30 AM Immunomedics to Host R&D Day - GlobeNewswire
Thu, Aug 28, 2008
4:00 PM Immunomedics Announces Fiscal 2008 Results - GlobeNewswire
Fri, Aug 01, 2008
10:30 AM Results With Epratuzumab in Children With Acute Lymphoblastic Leukemia Published in Journal of Clinical Oncology - GlobeNewswire
Tue, Jul 15, 2008
4:47 AM BeaconEquity.com Issues TraderNotes on Active Stocks: CELI, UVSE, GSPG, GNTA, AAPL, IMMU, EXAS, EEE - PR Newswire
Mon, Jul 14, 2008
8:30 AM Immunomedics Announces Worldwide License and Collaboration Agreement With Nycomed for Veltuzumab for Non-Cancer Indications - GlobeNewswire
Wed, Jun 18, 2008
8:30 AM Immunomedics Announces Fractionated Pretargeted Radioimmunotherapy Improves Pancreatic Cancer Therapy in Animal Model - GlobeNewswire
Tue, Jun 17, 2008
1:00 PM Immunomedics Develops Novel Radiotracer for Improved PET Imaging of Cancer - GlobeNewswire
Mon, Jun 16, 2008
12:30 PM Immunomedics' Pretargeting Method May Improve Radioimmunoimaging of Cancer - GlobeNewswire
Mon, Jun 09, 2008
8:30 AM Immunomedics to Present At the Society of Nuclear Medicine 55th Annual Meeting - GlobeNewswire
Mon, Jun 02, 2008
3:15 PM Immunomedics Reports Clinical Results in Lymphoma and Metastatic Colorectal Cancer With Radioimmunotherapy (RAIT) - GlobeNewswire
2:15 PM North Central Cancer Treatment Group Presents Phase II Study Results That Epratuzumab in Combination With Rituximab and Chemotherapy is Active, Safe and Tolerable in Aggressive Lymphoma - GlobeNewswire
8:33 AM Immunomedics Reports High Anti-Lymphoma Potency With Veltuzumab - GlobeNewswire
Tue, May 27, 2008
8:31 AM Immunomedics' Product Candidates Being Presented At 2008 ASCO Annual Meeting - GlobeNewswire
Wed, May 07, 2008
7:53 PM Immunomedics Announces Third Quarter Fiscal 2008 Results - GlobeNewswire
Wed, Apr 16, 2008
8:30 AM Immunomedics Creates Novel Cytokine Immunoconjugates Using Dock-and-Lock - GlobeNewswire
Tue, Apr 15, 2008
11:00 AM Immunomedics' Milatuzumab May Enhance Efficacies of Therapeutics for Multiple Myeloma in Preclinical Studies - GlobeNewswire
Mon, Apr 14, 2008
11:00 AM Immunomedics Reports Veltuzumab Enhances Radioimmunotherapy With Epratuzumab in Lymphoma Model - GlobeNewswire
8:31 AM Immunomedics' Pretargeting Method May Improve Radioimmunotherapy of Cancer - GlobeNewswire
Thu, Apr 10, 2008
8:32 AM Immunomedics' Product Candidates Being Presented At 2008 American Association for Cancer Research Annual Meeting - GlobeNewswire
Wed, Apr 09, 2008
8:31 AM Immunomedics Announces Results in Lymphoma Therapy With Veltuzumab Administered Subcutaneously - GlobeNewswire
Tue, Apr 08, 2008
12:39 PM Immunomedics Awarded U.S. Patent for Use of Anti-CD74 Immunoconjugates to Enhance Efficacy of Cancer and Infectious Disease Vaccines - GlobeNewswire
Thu, Mar 20, 2008
12:30 PM Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers - GlobeNewswire
Tue, Mar 18, 2008
8:30 AM Immunomedics' Milatuzumab Receives FDA Orphan Drug Designation for Therapy of Multiple Myeloma - GlobeNewswire
Thu, Feb 07, 2008
4:30 PM Immunomedics Announces Second Quarter Fiscal 2008 Results - GlobeNewswire
  Page 1 of 4   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for IMMU stock. Download IMMU report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download IMMU report
  
Example preview: Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU) Research report for Immunomedics, Inc (IMMU)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Immunomedics, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.